SYDNEY and SAN ANTONIO, July 30, 2025 /PRNewswire/ -- Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading provider of in-center ...
A new agent, liposomal cisplatin, in the treatment of relapsed or metastatic childhood solid tumors: Toxicity and clinical effectiveness. Treatment of multi-drug-resistant hepatoblastoma cells using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback